“…Neuropathological changes, such as tau-deposits, synaptic dysfunction, and neuronal loss, manifest very early in critical hubs of the human spatial navigation network such as the mesiotemporal lobe (i.e., hippocampus and entorhinal cortex) and RSC (Braak et al, 1993;Braak, 1995, 1998;Vlček and Laczó, 2014). Research in the last decades revealed that navigation deficits can be already found in patients with amnestic mild cognitive impairment (aMCI), which is thought to be a pre-stage of impeding dementia (Hort et al, 2007;Laczó et al, 2009Laczó et al, , 2010Lithfous et al, 2013;Vlček and Laczó, 2014;Rusconi et al, 2015;Kim J. W. et al, 2017). Spatial navigation testing, therefore, has great potential for the early diagnosis of aMCI/AD in pre-symptomatic stages (Coughlan et al, 2018).…”